Merrimack Pharmaceuticals (MACK) Stock Chart & Stock Price History → Could this Tiny Biotech End Disease Forever? (From Behind the Markets) (Ad) Free MACK Stock Alerts $15.03 -0.01 (-0.07%) (As of 04:00 PM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Merrimack Pharmaceuticals Stock Price Performance5 Day Performance+0.20%1 Month Performance+2.24%3 Month Performance+10.35%6 Month Performance+22.59%Year-To-Date Performance+12.08%1 Year Performance+15.62% Receive MACK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Merrimack Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaElon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. MACK Stock Chart for Wednesday, May, 8, 2024 MACK Chart by TradingView Merrimack Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$15.00$15.04+0.27%$15.06$15.00192,648 shs$218.53 million05/06/2024$15.00$15.00$15.03$15.0070,161 shs$217.95 million05/03/2024$15.03$15.00-0.20%$15.03$15.00187,562 shs$217.95 million05/02/2024$14.98$15.03+0.33%$15.03$14.96207,080 shs$218.39 million05/01/2024$14.74$14.98+1.63%$14.99$14.94310,213 shs$217.66 million04/30/2024$14.74$14.74$14.77$14.7382,222 shs$214.17 million Get the Latest News and Ratings for MACK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Merrimack Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$14.73$14.74+0.07%$14.80$14.7295,058 shs$214.17 million04/26/2024$14.73$14.73$14.76$14.7155,162 shs$214.03 million04/25/2024$14.71$14.73+0.14%$14.75$14.7082,841 shs$214.03 million04/24/2024$14.73$14.71-0.14%$14.77$14.71106,490 shs$213.74 million04/23/2024$14.73$14.73$14.78$14.7279,779 shs$214.03 million04/22/2024$14.72$14.73+0.07%$14.78$14.7195,000 shs$214.03 million04/19/2024$14.68$14.72+0.27%$14.73$14.6876,084 shs$213.88 million04/18/2024$14.68$14.68$14.71$14.67113,575 shs$213.30 million04/17/2024$14.68$14.68$14.71$14.67102,419 shs$213.30 million04/16/2024$14.68$14.68$14.70$14.66101,244 shs$213.30 million04/15/2024$14.68$14.68$14.73$14.67141,436 shs$213.30 million04/12/2024$14.73$14.68-0.34%$14.72$14.68109,432 shs$213.30 million04/11/2024$14.72$14.73+0.07%$14.75$14.7168,639 shs$214.03 million04/10/2024$14.73$14.72-0.07%$14.74$14.7192,910 shs$213.88 million04/09/2024$14.70$14.73+0.20%$14.75$14.7047,758 shs$214.06 million04/08/2024$14.71$14.70-0.07%$14.73$14.7097,061 shs$213.59 million04/05/2024$14.70$14.71+0.07%$14.78$14.70196,988 shs$213.74 million04/04/2024$14.71$14.70-0.07%$14.74$14.7082,348 shs$213.59 million04/03/2024$14.73$14.71-0.14%$14.75$14.7199,640 shs$213.74 million04/02/2024$14.74$14.73-0.07%$14.76$14.7090,872 shs$214.03 million04/01/2024$14.77$14.74-0.20%$14.82$14.74108,661 shs$214.17 million03/29/2024$14.77$14.77$14.85$14.75426,294 shs$214.64 million03/28/2024$14.75$14.77+0.14%$14.85$14.75413,038 shs$214.61 million03/27/2024$14.72$14.75+0.20%$14.80$14.7295,075 shs$214.32 million03/26/2024$14.73$14.72-0.07%$14.82$14.72103,473 shs$213.88 million03/25/2024$14.79$14.73-0.41%$14.91$14.7399,675 shs$214.03 million03/22/2024$14.69$14.79+0.68%$14.85$14.73193,562 shs$214.75 million03/21/2024$14.69$14.69$14.77$14.6989,846 shs$213.30 million03/20/2024$14.69$14.69$14.76$14.67106,498 shs$213.30 million03/19/2024$14.72$14.69-0.20%$14.77$14.6971,793 shs$213.30 million03/18/2024$14.74$14.72-0.14%$14.75$14.6891,728 shs$213.73 million03/15/2024$14.66$14.74+0.55%$14.76$14.64181,434 shs$214.03 million03/14/2024$14.69$14.66-0.20%$14.70$14.66101,749 shs$212.86 million03/13/2024$14.65$14.69+0.27%$14.72$14.64156,481 shs$213.30 millionRSVP: Charles Payne’s Cash Flow Workshop (Ad)Are you ready to find untapped value in the stocks you already own… Without selling a single share… Then you need to know these Cash Flow Trade Strategies.Register For Free Now!03/12/2024$14.66$14.65-0.07%$14.73$14.60117,220 shs$212.72 million03/11/2024$14.72$14.66-0.41%$14.74$14.6287,659 shs$212.86 million03/08/2024$14.77$14.72-0.34%$14.83$14.7097,171 shs$210.79 million03/07/2024$14.71$14.77+0.41%$14.78$14.7077,974 shs$211.51 million03/06/2024$14.69$14.71+0.14%$14.73$14.6956,505 shs$210.65 million03/05/2024$14.69$14.69$14.75$14.6876,389 shs$210.38 million03/04/2024$14.74$14.69-0.34%$14.77$14.6990,896 shs$210.36 million03/01/2024$14.70$14.74+0.27%$14.78$14.6887,897 shs$211.08 million02/29/2024$14.70$14.70$14.78$14.6951,739 shs$210.50 million02/28/2024$14.71$14.70-0.07%$14.76$14.6840,213 shs$210.50 million02/27/2024$14.70$14.71+0.07%$14.79$14.6845,109 shs$210.65 million02/26/2024$14.73$14.70-0.20%$14.80$14.6769,663 shs$210.50 million02/23/2024$14.72$14.73+0.07%$14.80$14.6666,315 shs$210.93 million02/22/2024$14.68$14.72+0.27%$14.75$14.6565,170 shs$210.79 million02/21/2024$14.70$14.68-0.14%$14.78$14.61127,502 shs$210.22 million02/20/2024$14.70$14.70$14.74$14.64185,138 shs$210.52 million02/19/2024$14.70$14.70$14.80$14.67239,900 shs$210.50 million02/16/2024$14.70$14.70$14.80$14.67239,938 shs$210.50 million02/15/2024$14.67$14.70+0.20%$14.80$14.62228,827 shs$210.52 million02/14/2024$15.00$14.67-2.20%$14.80$14.53701,628 shs$210.07 million02/13/2024$13.99$15.00+7.22%$15.89$13.601.27 million shs$214.80 million02/12/2024$13.80$13.99+1.38%$14.21$13.72118,954 shs$200.34 million02/09/2024$13.62$13.80+1.32%$13.85$13.34115,062 shs$197.62 million02/08/2024$13.06$13.62+4.29%$13.70$12.9484,793 shs$195.04 million02/07/2024$13.25$13.06-1.43%$13.25$13.0269,337 shs$187.02 million Related Companies: RIGL Stock Price Chart VSTM Stock Price Chart VNDA Stock Price Chart RGLS Stock Price Chart XOMA Stock Price Chart EBS Stock Price Chart LXRX Stock Price Chart OPK Stock Price Chart OVID Stock Price Chart GALT Stock Price Chart Receive MACK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Merrimack Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MACK) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityWatch this FREE trading tutorial while it’s still availableInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merrimack Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.